{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/L",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Cytostatika a imunomodula\u010Dn\u00ED l\u00E9\u010Diva" , "@language" : "cs" } ,        { "@value" : "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L01",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "ANTINEOPLASTIC AGENTS" , "@language" : "en" } ,        { "@value" : "Cytostatika" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L01" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L01X",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "OTHER ANTINEOPLASTIC AGENTS" , "@language" : "en" } ,        { "@value" : "Jin\u00E1 cytostatika" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L01X" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L01XA",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Platinov\u00E1 cytostatika" , "@language" : "cs" } ,        { "@value" : "Platinum compounds" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L01XA" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L01XA01",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/L01XA" ,        "http://linked.opendata.cz/resource/ATC/L01X" ,        "http://linked.opendata.cz/resource/ATC/L" ,        "http://linked.opendata.cz/resource/ATC/L01" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Cisplatin" , "@language" : "en" } ,        { "@value" : "Cisplatina" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L01XA01" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Drug hypersensitivity" , "@language" : "en" } ,        { "@value" : "L\u00E9kov\u00E1 alergie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000010195",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "T\u011Bhotenstv\u00ED" , "@language" : "cs" } ,        { "@value" : "Pregnancy" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000003529",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Selh\u00E1n\u00ED ledvin" , "@language" : "cs" } ,        { "@value" : "Kidney failure" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000002182",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Neutropenie" , "@language" : "cs" } ,        { "@value" : "Neutropenia" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000002932",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Thrombocytopenia" , "@language" : "en" } ,        { "@value" : "Trombocytopenie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0004505",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Cisplatin" , "@language" : "en" } ,        { "@value" : "Cisplatina" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPharmacologicalAction" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0005349" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0018388" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001483" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle.     " , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/D" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/contraindicatedWith" : [ "http://linked.opendata.cz/resource/ndfrt/disease/N0000003529" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000010195" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000002182" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000002932" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/CISPLATIN-HOSPIRA-0-5-MG-ML",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0004505" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "CISPLATIN HOSPIRA 0,5 MG/ML" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L01XA01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/D" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0163318" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0163320" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0163319" ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001483",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Antineoplastic agents" , "@language" : "en" } ,        { "@value" : "Antitumor\u00F3zn\u00ED l\u00E1tky" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Substances that inhibit or prevent the proliferation of NEOPLASMS.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0005349",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Reagencia zk\u0159\u00ED\u017Een\u011B v\u00E1zan\u00E1" , "@language" : "cs" } ,        { "@value" : "Cross-linking reagents" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0018388",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Radiation-sensitizing agents" , "@language" : "en" } ,        { "@value" : "Z\u00E1\u0159en\u00ED - l\u00E1tky senzibilizuj\u00EDc\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0163319",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "CISPLATIN HOSPIRA 0,5 MG/ML" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L01XA01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC144078_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "1X50ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Infuze" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.5MG/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Cisplatina je pou\u017E\u00EDv\u00E1na samostatn\u011B nebo jako sou\u010D\u00E1st zaveden\u00E9 kombinovan\u00E9 l\u00E9\u010Dby s dal\u0161\u00EDmi schv\u00E1len\u00FDmi chemoterapeutiky indikov\u00E1na k paliativn\u00ED l\u00E9\u010Db\u011B n\u00E1sleduj\u00EDc\u00EDch n\u00E1dorov\u00FDch onemocn\u011Bn\u00ED:  \n \nMetastazuj\u00EDc\u00ED testikul\u00E1rn\u00ED karcinom  \nJako sou\u010D\u00E1st zaveden\u00E9 kombinovan\u00E9 l\u00E9\u010Dby s jin\u00FDmi schv\u00E1len\u00FDmi chemoterapeutiky u pacient\u016F s metastazuj\u00EDc\u00EDm testikul\u00E1rn\u00EDm karcinomem, kte\u0159\u00ED ji\u017E byli l\u00E9\u010Deni chirurgicky a/nebo oz\u00E1\u0159en\u00EDm.  \n \nMetastazuj\u00EDc\u00ED ovari\u00E1ln\u00ED karcinom  \nJako sou\u010D\u00E1st zaveden\u00E9 kombinovan\u00E9 l\u00E9\u010Dby s jin\u00FDmi schv\u00E1len\u00FDmi chemoterapeutiky u pacientek s metastazuj\u00EDc\u00EDmi ovari\u00E1ln\u00EDmi n\u00E1dory, kter\u00E9 ji\u017E byly l\u00E9\u010Deny chirurgicky a/nebo oz\u00E1\u0159en\u00EDm.  Zavedena je kombinace cisplatiny a cyklofosfamidu.  \nCisplatina jako monoterapie je indikov\u00E1na jako sekund\u00E1rn\u00ED l\u00E9\u010Dba u pacientek s metastazuj\u00EDc\u00EDmi ovari\u00E1ln\u00EDmi n\u00E1dory, refraktern\u00EDmi v\u016F\u010Di standardn\u00ED chemoterapii, kter\u00E9 dosud nebyly l\u00E9\u010Deny cisplatinou.  \n \nPokro\u010Dil\u00FD karcinom mo\u010Dov\u00E9ho m\u011Bch\u00FD\u0159e  \nCisplatina jako monoterapie je indikov\u00E1na u pacient\u016F s karcinomem mo\u010Dov\u00E9ho m\u011Bch\u00FD\u0159e z p\u0159echodn\u00FDch bun\u011Bk, u n\u011Bho\u017E ji\u017E nen\u00ED vhodn\u00E1 lok\u00E1ln\u00ED l\u00E9\u010Dba nap\u0159. chirurgick\u00E1 a/nebo oz\u00E1\u0159en\u00EDm.  \n \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INF CNC SOL 1X50ML/25MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0163318",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "CISPLATIN HOSPIRA 0,5 MG/ML" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L01XA01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC144078_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "1X100ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Infuze" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.5MG/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Cisplatina je pou\u017E\u00EDv\u00E1na samostatn\u011B nebo jako sou\u010D\u00E1st zaveden\u00E9 kombinovan\u00E9 l\u00E9\u010Dby s dal\u0161\u00EDmi schv\u00E1len\u00FDmi chemoterapeutiky indikov\u00E1na k paliativn\u00ED l\u00E9\u010Db\u011B n\u00E1sleduj\u00EDc\u00EDch n\u00E1dorov\u00FDch onemocn\u011Bn\u00ED:  \n \nMetastazuj\u00EDc\u00ED testikul\u00E1rn\u00ED karcinom  \nJako sou\u010D\u00E1st zaveden\u00E9 kombinovan\u00E9 l\u00E9\u010Dby s jin\u00FDmi schv\u00E1len\u00FDmi chemoterapeutiky u pacient\u016F s metastazuj\u00EDc\u00EDm testikul\u00E1rn\u00EDm karcinomem, kte\u0159\u00ED ji\u017E byli l\u00E9\u010Deni chirurgicky a/nebo oz\u00E1\u0159en\u00EDm.  \n \nMetastazuj\u00EDc\u00ED ovari\u00E1ln\u00ED karcinom  \nJako sou\u010D\u00E1st zaveden\u00E9 kombinovan\u00E9 l\u00E9\u010Dby s jin\u00FDmi schv\u00E1len\u00FDmi chemoterapeutiky u pacientek s metastazuj\u00EDc\u00EDmi ovari\u00E1ln\u00EDmi n\u00E1dory, kter\u00E9 ji\u017E byly l\u00E9\u010Deny chirurgicky a/nebo oz\u00E1\u0159en\u00EDm.  Zavedena je kombinace cisplatiny a cyklofosfamidu.  \nCisplatina jako monoterapie je indikov\u00E1na jako sekund\u00E1rn\u00ED l\u00E9\u010Dba u pacientek s metastazuj\u00EDc\u00EDmi ovari\u00E1ln\u00EDmi n\u00E1dory, refraktern\u00EDmi v\u016F\u010Di standardn\u00ED chemoterapii, kter\u00E9 dosud nebyly l\u00E9\u010Deny cisplatinou.  \n \nPokro\u010Dil\u00FD karcinom mo\u010Dov\u00E9ho m\u011Bch\u00FD\u0159e  \nCisplatina jako monoterapie je indikov\u00E1na u pacient\u016F s karcinomem mo\u010Dov\u00E9ho m\u011Bch\u00FD\u0159e z p\u0159echodn\u00FDch bun\u011Bk, u n\u011Bho\u017E ji\u017E nen\u00ED vhodn\u00E1 lok\u00E1ln\u00ED l\u00E9\u010Dba nap\u0159. chirurgick\u00E1 a/nebo oz\u00E1\u0159en\u00EDm.  \n \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasResumedMarketingDate" : [ { "@value" : "2011-08-10" , "@type" : "http://www.w3.org/2001/XMLSchema#date" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasBreakMarketingDate" : [ { "@value" : "2011-10-17" , "@type" : "http://www.w3.org/2001/XMLSchema#date" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 359.2999877929688 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 337.3200073242188 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INF CNC SOL 1X100ML/50MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0163320",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "CISPLATIN HOSPIRA 0,5 MG/ML" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L01XA01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC144078_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "1X20ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Infuze" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.5MG/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Cisplatina je pou\u017E\u00EDv\u00E1na samostatn\u011B nebo jako sou\u010D\u00E1st zaveden\u00E9 kombinovan\u00E9 l\u00E9\u010Dby s dal\u0161\u00EDmi schv\u00E1len\u00FDmi chemoterapeutiky indikov\u00E1na k paliativn\u00ED l\u00E9\u010Db\u011B n\u00E1sleduj\u00EDc\u00EDch n\u00E1dorov\u00FDch onemocn\u011Bn\u00ED:  \n \nMetastazuj\u00EDc\u00ED testikul\u00E1rn\u00ED karcinom  \nJako sou\u010D\u00E1st zaveden\u00E9 kombinovan\u00E9 l\u00E9\u010Dby s jin\u00FDmi schv\u00E1len\u00FDmi chemoterapeutiky u pacient\u016F s metastazuj\u00EDc\u00EDm testikul\u00E1rn\u00EDm karcinomem, kte\u0159\u00ED ji\u017E byli l\u00E9\u010Deni chirurgicky a/nebo oz\u00E1\u0159en\u00EDm.  \n \nMetastazuj\u00EDc\u00ED ovari\u00E1ln\u00ED karcinom  \nJako sou\u010D\u00E1st zaveden\u00E9 kombinovan\u00E9 l\u00E9\u010Dby s jin\u00FDmi schv\u00E1len\u00FDmi chemoterapeutiky u pacientek s metastazuj\u00EDc\u00EDmi ovari\u00E1ln\u00EDmi n\u00E1dory, kter\u00E9 ji\u017E byly l\u00E9\u010Deny chirurgicky a/nebo oz\u00E1\u0159en\u00EDm.  Zavedena je kombinace cisplatiny a cyklofosfamidu.  \nCisplatina jako monoterapie je indikov\u00E1na jako sekund\u00E1rn\u00ED l\u00E9\u010Dba u pacientek s metastazuj\u00EDc\u00EDmi ovari\u00E1ln\u00EDmi n\u00E1dory, refraktern\u00EDmi v\u016F\u010Di standardn\u00ED chemoterapii, kter\u00E9 dosud nebyly l\u00E9\u010Deny cisplatinou.  \n \nPokro\u010Dil\u00FD karcinom mo\u010Dov\u00E9ho m\u011Bch\u00FD\u0159e  \nCisplatina jako monoterapie je indikov\u00E1na u pacient\u016F s karcinomem mo\u010Dov\u00E9ho m\u011Bch\u00FD\u0159e z p\u0159echodn\u00FDch bun\u011Bk, u n\u011Bho\u017E ji\u017E nen\u00ED vhodn\u00E1 lok\u00E1ln\u00ED l\u00E9\u010Dba nap\u0159. chirurgick\u00E1 a/nebo oz\u00E1\u0159en\u00EDm.  \n \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INF CNC SOL 1X20ML/10MG" , "@language" : "cs" } ] }] }